EN DE
STOCK COMPARISON

Jhpcy vs Sun Pharmaceutical Industries: Fair Value & Quality

Both stocks run through our valuation models. Here is how Jhpcy (JHPCY) and Sun Pharmaceutical Industries (SUNPHARMA) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees Sun Pharmaceutical Industries as the less overvalued of the two: Jhpcy trades at $13.60 versus a fair value of $6.86 (-50%), while Sun Pharmaceutical Industries trades at ₹1,945 versus ₹1,781 (-8%).
Jhpcy
JHPCY · USD · Healthcare
-50%
upside to fair value
overvalued
Price$13.60
Fair Value$6.86
Quality63/100
Sun Pharmaceutical Industries
SUNPHARMA.NSE · INR · Health Care
-8%
upside to fair value
fairly valued
Price₹1,945
Fair Value₹1,781
Quality65/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

JhpcySun Pharmaceutical Industries
Valuation
37.8×P/E (TTM)40.5×
—P/S (TTM)7.93×
—P/B5.55×
—EV/EBITDA27.7×
—PEG1.04×
0.4%Dividend yield0.8%
$0.20Dividend per share₹16.00
Profitability
25%Net margin20%
32%Operating margin19%
15%Return on equity15%
9%Return on assets8%
Growth
13%Revenue growth (YoY)13%
14.1%Avg. growth/yr (3Y)10.0%
—Avg. growth/yr (5Y)11.8%
Balance & size
$45BMarket cap$49B
healthyGrowth qualityhealthy

Jhpcy leads: 6 to 2 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Jhpcyof which business quality 66 · market factors 26 Sun Pharmaceutical Industriesof which business quality 65 · market factors 73
ProfitabilityMargins and returns on capital today
63
58
Quality GrowthAre margins and returns improving?
36
41
CashflowEarnings quality: real cash, not paper profit
82
62
Fin. StrengthBalance sheet, leverage, solvency risk
100
87
InvestmentDisciplined investing over empire-building
27
51
Low VolatilityCalm price path (market factor)
50
96
MomentumPrice trend over the last 3–12 months (market factor)
21
56
52W MomentumDistance to the 52-week high (market factor)
5
76
Net IssuanceBuybacks instead of dilution
55
81

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Jhpcy

DCF Models$64.47
Earnings-Based$34.35
Multiples$42.99
Asset-Based$12.37
Growth DCF$62.22
Economic Profit$31.56
Growth Earnings$48.18

1 of 24 models see the stock below the current price.

Sun Pharmaceutical Industries

DCF Models₹1,247
Earnings-Based₹689
Dividend Discount₹313
Multiples₹911
Asset-Based₹233
Growth DCF₹1,058
Economic Profit₹588
Growth Earnings₹1,039

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Jhpcy
Bear $5.14Fair Value $6.86Bull $8.75
$13.60 = current price (white tick)
Sun Pharmaceutical Industries
Bear ₹1,281Fair Value ₹1,781Bull ₹2,431
₹1,945 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Jhpcy · Healthcare

Quality score63 · Top 25%
Fair value upside-50% · below median

Sun Pharmaceutical Industries · Health Care

Quality score65 · Top 25%
Fair value upside-8% · above median

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees Sun Pharmaceutical Industries as the less overvalued of the two: Jhpcy trades at $13.60 versus a fair value of $6.86 (-50%), while Sun Pharmaceutical Industries trades at ₹1,945 versus ₹1,781 (-8%).

Sun Pharmaceutical Industries has the higher quality score (65/100).

See the full analysis →
Jhpcy · Sun Pharmaceutical Industries

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Jhpcy

Alphabet Inc Class C vs Verizon CommunicationsAlphabet Inc Class C vs At&tAlphabet Inc Class C vs NetEaseAmazon.com vs Toyota Motor Corporation

Related to Sun Pharmaceutical Industries

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.